Genprex, Inc.
Nasdaq: GNPXPharmaceutical Preparations · Entity-resolved by Clous
CIK0001595248
TickerGNPX
ExchangeNasdaq
SIC2834
StateTX
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2024-12-31
$0
—
Net IncomeFY2025-12-31
-$16.23M
+23.1% YoY
Total AssetsFY2025-12-31
$10.16M
+146.3% YoY
EquityFY2025-12-31
$7.96M
+391.4% YoY
Shares OutstandingFY2025-12-31
9.04M
—
Operating Cash FlowFY2025-12-31
-$15.31M
+10.7% YoY
Short interest & fails
Cost to borrow15.93%100K shares availablehard to borrow
Fails-to-deliver
SEC CNS fails · semi-monthly7.9K
shares failed · 2026-05-27
2026-05-277.9K sh$0.77
2026-05-26565 sh$0.82
2026-05-1915K sh$0.81
2026-05-181.09K sh$0.83
2026-05-1510.03K sh$0.86
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — | — | — |
| Net Income | -$23.74M | -$30.86M | -$21.11M | -$16.23M | +23.1% | — |
| Total Assets | $25.09M | $10.67M | $4.12M | $10.16M | +146.3% | — |
| Equity | $22.27M | $7.42M | $1.62M | $7.96M | +391.4% | — |
| Operating Cash Flow | -$17.78M | -$24.74M | -$17.15M | -$15.31M | +10.7% | — |
| Shares Outstanding | — | — | — | 9.04M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001595248